GH Research PLC
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Latest news
All 1KA.DU news ›Guardant Health (NASDAQ:GH) Research Coverage Started at Roth Capital
Roth Capital initiated coverage on shares of Guardant Health (NASDAQ:GH – Free Report) in a research report released on Thursday morning, MarketBeat Ratings reports. The brokerage issued a buy rating and a $200.00 price objective on the…
GH Research Remains Undervalued Ahead Of Pivotal Phase III Program
GH Research looks undervalued as GH001 targets treatment-resistant depression with strong potential. Click to read this bullish thesis on the GHRS stock. - GH Research remains significantly undervalued due to the large unmet need in…
GH Research to present trial data on October 11, 2026
Three trial posters from GH Research (GHRS) are scheduled for October 11, 2026, in Munich. Stock Titan - [6-K] GH Research PLC Current Report (Foreign Issuer) GH Research to present trial data on October 11, 2026 The meeting schedule…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- defenseworld.net1
- seekingalpha.com1
- stocktitan.net1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.